(Q81488462)

English

Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand

scientific article published on 01 March 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

based on heuristic

inferred from title

phase I clinical trial

1 reference

based on heuristic

inferred from title

Deborah L. Birx

12

object named as

Deborah L Birx

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Josephine H Cox

3

object named as

Josephine H Cox

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Chitraporn Karnasuta

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Robert M Paris

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sorachai Nitayaphan

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Punnee Pitisuttithum

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Prasert Thongcharoen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Arthur E Brown

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sanjay Gurunathan

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

James Tartaglia

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

William L Heyward

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

John G McNeil

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Mark S de Souza

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Thai AIDS Vaccine Evaluation Group, Thailand

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

2522-2529

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Host factors and the pathogenesis of HIV-induced disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Host factors in the pathogenesis of HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Antibody-dependent cellular cytotoxicity in HIV infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Anti-HIV-1 ADCC.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1--infected women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Antibody-dependent cellular cytotoxicity mediated by CD16+ lymphocytes from HIV-seropositive homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Innate immunity to herpes simplex virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her-2/neu

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Taxanes Synergize with the Bispecific Antibody MDXH447 to Enhance Antibody-Dependent Cell-Mediated Cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4+ lymphocyte count.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Sustained antibody-dependent cell-mediated cytotoxicity (ADCC) in SIV-infected macaques correlates with delayed progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Longitudinal study of humoral immune responses in HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Antibody-dependent cellular cytotoxicity in HIV type 1-infected patients receiving VaxSyn, a recombinant gp160 envelope vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

gp120-directed antibody-dependent cellular cytotoxicity as a major determinant of the rate of decline in CD4 percentage in HIV-1 disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Broadly reactive HIV-2 and SIVmac specific antibody-dependent cellular cytotoxicity in immunized and infected cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

HIV-specific cellular and humoral immune responses in primary HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

HIV-1-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

A comparative study of the impact of HIV infection on natural killer cell number and function in Thais and North Americans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Predominance of detrimental humoral immune responses to HIV-1 in AIDS patients with CD4 lymphocyte counts less than 400/mm3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Identification of cross-reactive antigenic target regions for HIV type 1-specific antibody-dependent cellular cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Association between anti-human immunodeficiency virus type 1 (HIV-1) antibody-dependent cellular cytotoxicity antibody titers at birth and vertical transmission of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Relationships between humoral factors in HIV-1-infected mothers and the occurrence of HIV infection in their infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Delayed generation of antibodies mediating human immunodeficiency virus type 1-specific antibody-dependent cellular cytotoxicity in vertically infected infants. WITS Study Group. Women and Infants Transmission Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Failure of ADCC to predict HIV-associated disease progression or outcome in a haemophiliac cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Long-Term Human Immunodeficiency Virus Infection in Asymptomatic Homosexual and Bisexual Men with Normal CD4+ Lymphocyte Counts: Immunologic and Virologic Characteristics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.10.028

7 January 2021

Identifiers

10.1016/J.VACCINE.2004.10.028

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15752839%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81488462&oldid=1767475495"